Ralph Lipp

613 total citations
27 papers, 487 citations indexed

About

Ralph Lipp is a scholar working on Pharmaceutical Science, Molecular Biology and Immunology. According to data from OpenAlex, Ralph Lipp has authored 27 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmaceutical Science, 11 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Ralph Lipp's work include Advancements in Transdermal Drug Delivery (9 papers), Mast cells and histamine (9 papers) and Drug Solubulity and Delivery Systems (7 papers). Ralph Lipp is often cited by papers focused on Advancements in Transdermal Drug Delivery (9 papers), Mast cells and histamine (9 papers) and Drug Solubulity and Delivery Systems (7 papers). Ralph Lipp collaborates with scholars based in Germany, United States and France. Ralph Lipp's co-authors include Adrian Funke, Clemens Günther, M. Garbarg, Torsten Wagner, H. Kranz, Walter Schunack, Rainer Müller, Thomas Wagner, Holger Stark and Peter Luger and has published in prestigious journals such as Journal of Controlled Release, Journal of Medicinal Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Ralph Lipp

27 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Lipp Germany 12 277 116 109 61 52 27 487
Toshio Inagi Japan 15 309 1.1× 80 0.7× 39 0.4× 100 1.6× 50 1.0× 23 526
Sydney O. Ugwu United States 11 160 0.6× 393 3.4× 36 0.3× 28 0.5× 60 1.2× 21 768
Anita Sztojkov‐Ivanov Hungary 13 216 0.8× 144 1.2× 14 0.1× 17 0.3× 53 1.0× 26 480
Anam Khan Pakistan 8 250 0.9× 175 1.5× 54 0.5× 23 0.4× 13 0.3× 10 451
Nina Østergaard Knudsen Denmark 10 148 0.5× 120 1.0× 44 0.4× 103 1.7× 14 0.3× 13 346
Pramod P. Sarpotdar United States 9 350 1.3× 95 0.8× 13 0.1× 136 2.2× 79 1.5× 10 480
Vamshi Krishna Tippavajhala India 10 167 0.6× 79 0.7× 18 0.2× 42 0.7× 16 0.3× 50 342
Saroj K. Ghosal India 10 295 1.1× 57 0.5× 7 0.1× 59 1.0× 76 1.5× 15 442
Gopal Venkatesh Shavi India 16 329 1.2× 195 1.7× 29 0.3× 6 0.1× 43 0.8× 21 680
J.D. Pipkin United States 16 209 0.8× 175 1.5× 9 0.1× 6 0.1× 58 1.1× 34 529

Countries citing papers authored by Ralph Lipp

Since Specialization
Citations

This map shows the geographic impact of Ralph Lipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Lipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Lipp more than expected).

Fields of papers citing papers by Ralph Lipp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Lipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Lipp. The network helps show where Ralph Lipp may publish in the future.

Co-authorship network of co-authors of Ralph Lipp

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Lipp. A scholar is included among the top collaborators of Ralph Lipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Lipp. Ralph Lipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lipp, Ralph, et al.. (2008). Development of a novel osmotically driven drug delivery system for weakly basic drugs. European Journal of Pharmaceutics and Biopharmaceutics. 69(2). 667–674. 11 indexed citations
2.
Lipp, Ralph, et al.. (2007). Development of a Multiple Unit Pellet Formulation for a Weakly Basic Drug. Drug Development and Industrial Pharmacy. 33(3). 341–349. 16 indexed citations
3.
Harrison, Lester I., et al.. (2007). Simultaneous Estradiol and Levonorgestrel Transdermal Delivery from a 7-day Patch: In Vitro and In Vivo Drug Deliveries of Three Formulations. Drug Development and Industrial Pharmacy. 33(4). 373–380. 10 indexed citations
4.
Funke, Adrian, et al.. (2006). Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds. International Journal of Pharmaceutics. 329(1-2). 173–181. 66 indexed citations
5.
Kranz, H., et al.. (2005). Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. European Journal of Pharmaceutical Sciences. 26(1). 47–53. 51 indexed citations
6.
Lipp, Ralph, et al.. (2005). Evaluation of the Transdermal Permeation Behavior of Proterguride from Drug in Adhesive Matrix Patches Through Hairless Mouse Skin. Drug Development and Industrial Pharmacy. 31(6). 505–513. 6 indexed citations
7.
Funke, Adrian, Clemens Günther, Rainer Müller, & Ralph Lipp. (2003). Development of Matrix Patches for Transdermal Delivery of a Highly Lipophilic Antiestrogen. Drug Development and Industrial Pharmacy. 29(7). 785–793. 4 indexed citations
8.
Funke, Adrian, Clemens Günther, Rainer Müller, & Ralph Lipp. (2002). In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS. Journal of Controlled Release. 82(1). 63–70. 18 indexed citations
9.
Funke, Adrian, et al.. (2002). Transdermal Delivery of Highly Lipophilic Drugs: In Vitro Fluxes of Antiestrogens, Permeation Enhancers, and Solvents from Liquid Formulations. Pharmaceutical Research. 19(5). 661–668. 64 indexed citations
10.
11.
Lipp, Ralph. (1998). Selection and Use of Crystallization Inhibitors for Matrix-type Transdermal Drug-delivery Systems Containing Sex Steroids. Journal of Pharmacy and Pharmacology. 50(12). 1343–1349. 45 indexed citations
12.
Lipp, Ralph, et al.. (1998). Prodrugs of Gestodene for Matrix-Type Transdermal Drug Delivery Systems. Pharmaceutical Research. 15(9). 1419–1424. 7 indexed citations
13.
Ligneau, Xavier, et al.. (1997). ヒスタミンH 3 受容器きっ抗薬に対する新しいリード構造の探索 アミン誘導体. Pharmazie. 52(6). 419–423. 4 indexed citations
14.
Stark, Holger, et al.. (1997). Search for novel leads for histamine H3-receptor antagonists: amine derivatives.. PubMed. 52(6). 419–23. 1 indexed citations
15.
Krause, Michael, A. Rouleau, Holger Stark, et al.. (1995). Synthesis, X-ray Crystallography, and Pharmacokinetics of Novel Azomethine Prodrugs of (R)-.alpha.-Methylhistamine: Highly Potent and Selective Histamine H3 Receptor Agonists. Journal of Medicinal Chemistry. 38(20). 4070–4079. 40 indexed citations
16.
Lipp, Ralph, Holger Stark, JM Arrang, et al.. (1995). Synthesis and histamine H3-receptor agonist activity of mono- and dialkyl-substituted histamine derivatives. European Journal of Medicinal Chemistry. 30(3). 219–225. 3 indexed citations
17.
18.
Arrang, J.M., M. Garbarg, J. Schwartz, et al.. (1991). The Histamine H3-Receptor: Pharmacology, Roles and Clinical Implications Studied with Agonists. Birkhäuser Basel eBooks. 33. 55–67. 14 indexed citations
19.
Kleine‐Tebbe, Jörg, et al.. (1990). Influence of histamine H3-antagonists on human leukocytes. Inflammation Research. 30(1-2). 137–139. 11 indexed citations
20.
Altman, Janina, Meir Wilchek, Ralph Lipp, & Walter Schunack. (1989). An Improved Synthesis of L-Homohistidine. Synthetic Communications. 19(11-12). 2069–2076. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshio Inagi Breakdown of academic impact, for papers by Sydney O. Ugwu Breakdown of academic impact, for papers by Anita Sztojkov‐Ivanov Breakdown of academic impact, for papers by Anam Khan Breakdown of academic impact, for papers by Nina Østergaard Knudsen Breakdown of academic impact, for papers by Pramod P. Sarpotdar Breakdown of academic impact, for papers by Vamshi Krishna Tippavajhala Breakdown of academic impact, for papers by Saroj K. Ghosal Breakdown of academic impact, for papers by Gopal Venkatesh Shavi Breakdown of academic impact, for papers by J.D. Pipkin
Rankless by CCL
2026